Taiwan to India: Tiotropium Import Trade Route

The Taiwan to India Tiotropium corridor is one of India's established pharmaceutical import routes from Taiwan, with 1 shipments documented worth a combined $1.5K USD. The route is dominated by CHINA CHEMICAL & PHARMACEUTICAL CO., LTD, which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Taiwan's tiotropium export sector.

Across 1 active Taiwan suppliers, the average shipment value stands at $1.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during April–June, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 13.4%, placing it at rank #7 among India's top tiotropium import origins globally.

On the Indian buyer side, key Indian importers include CIPLA LIMITED. CIPLA LIMITED is the single largest Indian importer with 1 shipments valued at $1.5K USD.

India's tiotropium imports from Taiwan are driven primarily by a handful of large-scale Taiwan manufacturers. CHINA CHEMICAL & PHARMACEUTICAL CO., LTD with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from Taiwan supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CHINA CHEMICAL & PHARMACEUTICAL CO., LTD — together account for 100% of total trade value on this route. The average shipment value of $1.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, CIPLA LIMITED is the largest importer with 1 shipments worth $1.5K USD — representing 100% of all tiotropium imports from Taiwan on this route.